Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. BriaCell Therapeutics Corp.
  6. News
  7. Summary
    BCT   CA10778Y3023

BRIACELL THERAPEUTICS CORP.

(BCT)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Sliding to Small Declines

06/02/2021 | 01:42pm EDT


© MT Newswires 2021
All news about BRIACELL THERAPEUTICS CORP.
07/19BRIACELL THERAPEUTICS CORP.(TSXV : BCT) added to S&P/TSX Venture Composite Index
CI
07/14BRIACELL THERAPEUTICS : Phase I/IIa Clinical Trial Combination Study in Advanced..
PU
07/14BRIACELL THERAPEUTICS : Opens Enrollment for Breast Cancer Study With Incyte
MT
07/14BRIACELL THERAPEUTICS : Phase I/IIa Clinical Trial Combination Study in Advanced..
AQ
07/14BriaCell Therapeutics Corp. Announces Phase I/IIa Clinical Trial Combination ..
CI
06/30BriaCell Therapeutics Corp. Announces Unaudited Consolidated Earnings Results..
CI
06/16BRIACELL THERAPEUTICS : Expands Breast Cancer Platform Technology into Prostate,..
PU
06/16Briacell Therapeutics Expands Breast Cancer Platform Technology into Prostate..
CI
06/10BRIACELL THERAPEUTICS : Announces Proceeds of US$12.88 Million from Warrant Exer..
PU
06/09BRIACELL TO HOLD CORPORATE AND CLINI : 30 p.m. ET (Form 6-K)
PU
More news
Financials
Sales 2020 - - -
Net income 2020 -4,94 M -3,96 M -3,96 M
Net Debt 2020 0,28 M 0,23 M 0,23 M
P/E ratio 2020 -1,38x
Yield 2020 -
Capitalization 98,0 M 78,6 M 78,6 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 6
Free-Float 85,9%
Chart BRIACELL THERAPEUTICS CORP.
Duration : Period :
BriaCell Therapeutics Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
William V. Williams President, Chief Executive Officer & Director
Gadi Levin Chief Financial Officer & Secretary
Jamieson Bondarenko Chairman
Miguel A. Lopez-Lago Senior Director-Research & Development
Rebecca A. Taub Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BRIACELL THERAPEUTICS CORP.7.36%79
GILEAD SCIENCES, INC.19.86%85 648
BIONTECH SE302.78%79 303
WUXI APPTEC CO., LTD.33.61%68 112
REGENERON PHARMACEUTICALS20.70%59 505
VERTEX PHARMACEUTICALS-14.71%52 232